SCHEMBL38656278

SCHEMBL38656278

C[Si](C)(C)CCOCn1nnc2cc(Br)ccc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
NPC1 O15118 5/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
RAB9A P51151 3/20 0.40
DGAT1 O75907 2/20 0.39
POLB P06746 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
TSHR P16473 4/20 0.37
HSD17B10 Q99714 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38656231 0.90 MEN1 (0.41) KMT2AMEN1HTTNPC1MAPT
SCHEMBL3782203 0.82 DGAT1 (0.42) KMT2AMEN1NPC1RAB9ADGAT1
SCHEMBL26645068 0.80 DGAT1 (0.42) KMT2AMEN1NPC1RAB9ADGAT1
SCHEMBL20401447 0.78 NPC1 (0.43) KMT2AMEN1NPC1MAPTSMN1; SMN2
SCHEMBL23576644 0.76 NPC1 (0.41) KMT2AMEN1NPC1MAPTDGAT1
SCHEMBL29909620 0.76 NPC1 (0.41) KMT2AMEN1NPC1MAPTDGAT1
SCHEMBL38656212 0.76 NPC1 (0.43) KMT2AMEN1NPC1MAPTSMN1; SMN2
SCHEMBL23577034 0.74 MAPT (0.44) KMT2AMEN1NPC1MAPTSMN1; SMN2
SCHEMBL29909113 0.74 MAPT (0.44) KMT2AMEN1NPC1MAPTSMN1; SMN2
SCHEMBL16537098 0.73 DGAT1 (0.37) DGAT1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026102082-A1 ALKYLPHENYL SUBSTITUTED COMPOUNDS, COMPOSITIONS AND METHODS OF USE DEEP APPLE THERAPEUTICS, INC. (US) 2026-05-15 WO disclosed
US-20260132119-A1 Alkylphenyl Substituted Compounds, Compositions and Methods of Use DEEP APPLE THERAPEUTICS, INC. (US) 2026-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132119-A1 Alkylphenyl Substituted Compounds, Compositions and Methods of Use GIPR, MC2R, GRPR KMT2A 4321/4885MEN1 1814/4885HTT 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.